Average Co-Inventor Count = 4.54
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck & Cie (7 from 18 patents)
2. Biomarin Pharmaceutical Inc. (4 from 135 patents)
3. Merck Eprova Ag (3 from 6 patents)
4. Eprova Ag (1 from 16 patents)
14 patents:
1. 12122783 - Stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid
2. 12103930 - Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
3. 11306094 - Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
4. 10570134 - Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
5. 10336758 - Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
6. 10059710 - Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
7. 9993481 - Methods and compositions for the treatment of metabolic disorders
8. 9433624 - Methods and compositions for the treatment of metabolic disorders
9. 8344139 - Process for preparing crystalline polymorphic forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride
10. 8318745 - Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride
11. 8067416 - Methods and compositions for the treatment of metabolic disorders
12. 7727987 - Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride
13. 7566714 - Methods and compositions for the treatment of metabolic disorders
14. 6441168 - Stable crystalline salts of 5-methyltetrahydrofolic acid